Orocidin, Syngene develop cGMP manufacturing process for peptide therapy
Source: SeekingAlpha
2025-10-20 09:13:07 ET
More on Nordicus Partners Corporation
Read the full article on Seeking Alpha
For further details see:
Orocidin, Syngene develop cGMP manufacturing process for peptide therapy
Nord Anglia Education Inc.
NASDAQ: NORD
NORD Trading
0.02% G/L:
$4.04 Last:
1,650 Volume:
$4.01 Open:
NORD Latest News
October 22, 2025 09:00:00 am
Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.
October 20, 2025 09:00:00 am
Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
NORD Stock Data
$84,476,938
4,378,165
35.79%
3
398%
Corporate Services
Industrials
US
Beverly Hills
